These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37921603)

  • 1. Study of neoadjuvant chemotherapy in advanced malignant ovarian germ cell tumors at a tertiary center in western India.
    Vasanth A; Patel SM; Arora R; Parekh CD; Dave P; Patel BM; Vemanamandhi P
    J Gynecol Oncol; 2024 Mar; 35(2):e19. PubMed ID: 37921603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neo-adjuvant chemotherapy in the treatment of advanced malignant germ cell tumors of ovary.
    Talukdar S; Kumar S; Bhatla N; Mathur S; Thulkar S; Kumar L
    Gynecol Oncol; 2014 Jan; 132(1):28-32. PubMed ID: 24145115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fertility-sparing surgery for patients with malignant ovarian germ cell tumors: 10 years of clinical experience from a tertiary referral center.
    Mikuš M; Benco N; Matak L; Planinić P; Ćorić M; Lovrić H; Radošević V; Puževski T; Bajt M; Vujić G
    Arch Gynecol Obstet; 2020 May; 301(5):1227-1233. PubMed ID: 32253553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is carboplatin-based chemotherapy as effective as cisplatin-based chemotherapy in the treatment of advanced-stage dysgerminoma in children, adolescents and young adults?
    Shah R; Xia C; Krailo M; Amatruda JF; Arul SG; Billmire DF; Brady WE; Covens A; Gershenson DM; Hale JP; Hurteau J; Murray MJ; Nicholson JC; Olson TA; Pashankar F; Rodriguez-Galindo C; Shaikh F; Stark D; Frazier AL; Stoneham S
    Gynecol Oncol; 2018 Aug; 150(2):253-260. PubMed ID: 29884437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fertility sparing surgery in malignant ovarian Germ cell tumor (MOGCT): 15 years experiences.
    Zamani N; Rezaei Poor M; Ghasemian Dizajmehr S; Alizadeh S; Modares Gilani M
    BMC Womens Health; 2021 Aug; 21(1):282. PubMed ID: 34348686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Need for risk-adapted therapy for malignant ovarian germ cell tumors: A large multicenter analysis of germ cell tumors' patients from French TMRG network.
    Derquin F; Floquet A; Hardy-Bessard AC; Edeline J; Lotz JP; Alexandre J; Pautier P; Angeles MA; Delanoy N; Lefeuvre-Plesse C; Cancel M; Treilleux I; Augereau P; Lavoue V; Kalbacher E; Berton Rigaud D; Selle F; Nadeau C; Gantzer J; Joly F; Guillemet C; Pomel C; Favier L; Abdeddaim C; Venat-Bouvet L; Provansal M; Fabbro M; Kaminsky MC; Lortholary A; Lecuru F; Coquard IR; de La Motte Rouge T
    Gynecol Oncol; 2020 Sep; 158(3):666-672. PubMed ID: 32624235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Strategy for the Treatment of Ovarian Germ Cell Tumors: Role of Extensive Surgery.
    Li J; Wu X
    Curr Treat Options Oncol; 2016 Aug; 17(8):44. PubMed ID: 27357180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicentre retrospective cohort study of ovarian germ cell tumours: Evidence for chemotherapy de-escalation and alignment of paediatric and adult practice.
    Newton C; Murali K; Ahmad A; Hockings H; Graham R; Liberale V; Sarker SJ; Ledermann J; Berney DM; Shamash J; Banerjee S; Stoneham S; Lockley M
    Eur J Cancer; 2019 May; 113():19-27. PubMed ID: 30954883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fertility-Sparing Surgery Should Be the Standard Treatment in Patients with Malignant Ovarian Germ Cell Tumors.
    Turkmen O; Karalok A; Basaran D; Kimyon GC; Tasci T; Ureyen I; Tulunay G; Turan T
    J Adolesc Young Adult Oncol; 2017 Jun; 6(2):270-276. PubMed ID: 28085535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors. A review of 74 cases.
    Low JJ; Perrin LC; Crandon AJ; Hacker NF
    Cancer; 2000 Jul; 89(2):391-8. PubMed ID: 10918171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of malignant ovarian germ cell tumors and preservation of fertility.
    Zhang R; Sun YC; Zhang GY; Wu LY; Zuo J
    Eur J Gynaecol Oncol; 2012; 33(5):489-92. PubMed ID: 23185794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant Chemotherapy Followed by Vaginal Radical Trachelectomy as Fertility-Preserving Treatment for Patients with FIGO 2018 Stage 1B2 Cervical Cancer.
    Zusterzeel PLM; Aarts JWM; Pol FJM; Ottevanger PB; van Ham MAPC
    Oncologist; 2020 Jul; 25(7):e1051-e1059. PubMed ID: 32339376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical analysis of 15 cases of malignant ovarian germ cell tumors with lung metastasis].
    Liu Y; Ren T; Feng FZ; Wan XR; Shen K; Xiang Y
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):40-4. PubMed ID: 22455692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary debulking surgery versus primary neoadjuvant chemotherapy for high grade advanced stage ovarian cancer: comparison of survivals.
    Kobal B; Noventa M; Cvjeticanin B; Barbic M; Meglic L; Herzog M; Bordi G; Vitagliano A; Saccardi C; Skof E
    Radiol Oncol; 2018 Sep; 52(3):307-319. PubMed ID: 30210049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term oncological and reproductive outcomes of fertility-sparing cytoreductive surgery in females aged 25 years and younger with malignant ovarian germ cell tumors.
    Ertas IE; Taskin S; Goklu R; Bilgin M; Goc G; Yildirim Y; Ortac F
    J Obstet Gynaecol Res; 2014 Mar; 40(3):797-805. PubMed ID: 24320102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of malignant ovarian germ-cell tumors treated in Chiang Mai University Hospital over a nine year period.
    Neeyalavira V; Suprasert P
    Asian Pac J Cancer Prev; 2014; 15(12):4909-13. PubMed ID: 24998562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MALIGNANT OVARIAN GERM CELL TUMORS AT A TERTIARY CARE SETTING IN PAKISTAN.
    Hannan A; Malik MA; Fasih S; Badar F; Siddiqui N
    J Ayub Med Coll Abbottabad; 2015; 27(3):624-7. PubMed ID: 26721024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Residual tumor after the salvage surgery is the major risk factors for primary treatment failure in malignant ovarian germ cell tumors: a retrospective study of single institution.
    Lee CW; Song MJ; Park ST; Ki EY; Lee SJ; Lee KH; Ryu KS; Park JS; Hur SY
    World J Surg Oncol; 2011 Oct; 9():123. PubMed ID: 21988930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of pediatric and adolescent girls with malignant ovarian germ cell tumors.
    Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    Gynecol Oncol; 2015 Jun; 137(3):418-22. PubMed ID: 25842162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of bilateral malignant ovarian germ cell tumors: a MITO-9 retrospective study.
    Sigismondi C; Scollo P; Ferrandina G; Candiani M; Angioli R; Viganò R; Scarfone G; Mangili G
    Int J Gynecol Cancer; 2015 Feb; 25(2):203-7. PubMed ID: 25569816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.